Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Peritoneal Neoplasms × Saline Waters × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Peritoneal Neoplasms 1

Interventions

Paclitaxel 21 Cisplatin 21 Hyperthermic Intraperitoneal Chemotherapy 20 Oxaliplatin 15 Carboplatin 14 Cytoreduction Surgical Procedures 12 Fluorouracil 11 Bevacizumab 9 Doxorubicin 8 Mitomycin 7 Leucovorin 6 Docetaxel 6 Surgical Procedures, Operative 4 Gemcitabine 4 Blood Specimen Collection 4 130-nm albumin-bound paclitaxel 4 sodium thiosulfate 3 catumaxomab 3 Neoadjuvant Therapy 3 Drug Therapy 3 Albumin-Bound Paclitaxel 3 tremelimumab 2 relacorilant 2 pembrolizumab 2 olaparib 2 nintedanib 2 liposomal doxorubicin 2 Taxes 2 Platinum 2 Palliative Care 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡